The evidence for this mechanism in humans is biologically plausible but not yet conclusively established in high-quality clinical trials see the evidence table
Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not
Available from: Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S
The safety profile of AOD-9604 allows for extended use
Natural Extracts: Botanical extracts such as licorice root, arbutin, and kojic acid work synergistically to brighten the skin and fade dark spots
One study showed that injections of semaglutide (the active ingredient in Wegovy), which is administered for diabetes or weight loss in the skin of the abdomen, thigh or upper arm, produced little to no injectionsite pain